X-137030751-C-G
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_054021.2(GPR101):c.924G>C(p.Glu308Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00476 in 1,209,166 control chromosomes in the GnomAD database, including 15 homozygotes. There are 1,903 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E308K) has been classified as Uncertain significance.
Frequency
Consequence
NM_054021.2 missense
Scores
Clinical Significance
Conservation
Publications
- pituitary adenoma, growth hormone-secreting, 2Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- acromegalyInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00344 AC: 382AN: 110993Hom.: 1 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.00353 AC: 647AN: 183283 AF XY: 0.00365 show subpopulations
GnomAD4 exome AF: 0.00489 AC: 5368AN: 1098119Hom.: 14 Cov.: 32 AF XY: 0.00499 AC XY: 1812AN XY: 363479 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00344 AC: 382AN: 111047Hom.: 1 Cov.: 22 AF XY: 0.00274 AC XY: 91AN XY: 33259 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Pituitary adenoma, growth hormone-secreting, 2 Pathogenic:1Uncertain:1Other:1
- -
- -
- -
not provided Benign:3
- -
- -
- -
GPR101-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at